Jason Alacapa
Biographic Data
| ID | 9799119 |
|---|---|
| NAME | Jason Alacapa |
| GIVEN NAMES | Jason |
| FAMILY NAME | Alacapa |
| SIGNATURE | ALACAPA J |
| AFFILIATIONS | Japan Foundation Manila |
| ORCID | 0000-0002-0794-3947 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Feasibility and acceptability of the smart pillbox and medication label with differentiated care to support person-centered tuberculosis care among Ascent trial participants – A multicountry study
Introduction: Digital adherence technologies (DATs) can offer alternative approaches to support tuberculosis treatment medication adherence. Evidence on their feasibility and acceptability in high TB burden settings is limited. We conducted a cross-sectional survey among adults with drug-sensitive tuberculosis (DS-TB), participating in pragmatic cluster-randomized trials for the Adherence Support Coalition to End TB project in Ethiopia (PACTR2020…
Modelling the epidemiological and economic impact of digital adherence technologies with differentiated care for tuberculosis treatment in Ethiopia
BACKGROUND: Digital adherence technologies (DATs) with associated differentiated care are potential tools to improve tuberculosis (TB) treatment outcomes and reduce associated costs for both patients and healthcare providers. However, the balance between epidemiological and economic benefits remains unclear. Here, we used data from the ASCENT trial to estimate the potential long-term epidemiological and economic impact of DAT interventions in Eth…
Telemedicine Across the Globe-Position Paper From the Covid-19 Pandemic Health System Resilience PROGRAM (Reprogram) International Consortium (Part 1)
Coronavirus disease 2019 (COVID-19) has accelerated the adoption of telemedicine globally. The current consortium critically examines the telemedicine frameworks, identifies gaps in its implementation and investigates the changes in telemedicine framework/s during COVID-19 across the globe. Streamlining of global public health preparedness framework that is interoperable and allow for collaboration and sharing of resources, in which telemedicine …
No prominent works on this page.
Telemedicine Across the Globe-Position Paper From the Covid-19 Pandemic Health System Resilience PROGRAM (Reprogram) International Consortium (Part 1)
Coronavirus disease 2019 (COVID-19) has accelerated the adoption of telemedicine globally. The current consortium critically examines the telemedicine frameworks, identifies gaps in its implementation and investigates the changes in telemedicine framework/s during COVID-19 across the globe. Streamlining of global public health preparedness framework that is interoperable and allow for collaboration and sharing of resources, in which telemedicine …
Feasibility and acceptability of the smart pillbox and medication label with differentiated care to support person-centered tuberculosis care among Ascent trial participants – A multicountry study
Introduction: Digital adherence technologies (DATs) can offer alternative approaches to support tuberculosis treatment medication adherence. Evidence on their feasibility and acceptability in high TB burden settings is limited. We conducted a cross-sectional survey among adults with drug-sensitive tuberculosis (DS-TB), participating in pragmatic cluster-randomized trials for the Adherence Support Coalition to End TB project in Ethiopia (PACTR2020…
Modelling the epidemiological and economic impact of digital adherence technologies with differentiated care for tuberculosis treatment in Ethiopia
BACKGROUND: Digital adherence technologies (DATs) with associated differentiated care are potential tools to improve tuberculosis (TB) treatment outcomes and reduce associated costs for both patients and healthcare providers. However, the balance between epidemiological and economic benefits remains unclear. Here, we used data from the ASCENT trial to estimate the potential long-term epidemiological and economic impact of DAT interventions in Eth…
Health care (3 works) · Medicine (3 works) · Nursing (3 works) · Mobile Health and mHealth Applications (2 works) · Public health (2 works) · Tuberculosis (2 works) · Tuberculosis Research and Epidemiology (2 works) · Business (1 works) · Cluster randomised controlled trial (1 works) · Computer Science (1 works)